Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatmentTomohiro Yabushita, Susumu Goyama, Keita Yamamoto et al.|Cell Reports|2023Cited by 28
[Activities of antimicrobial agents against 5,180 clinical isolates obtained from 26 medical institutions during 1998 in Japan. Levofloxacin--Surveillance Group].K Yamaguchi, Isamu Nakasone, S Miyazaki et al.|PubMed|2000Cited by 16
Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor TreatmentTomohiro Yabushita, Susumu Goyama, Takumi Chinen et al.|Blood|2022Cited by 3